Yearly Archives: 2021

Thriving & Challenging Yourself While Living with GIST, Elyse, Part 1

GIST patients face many obstacles and challenges to get to a place where they’d say they were thriving. Physical challenges from surgeries, pain and side effects can severely change the lifestyle and activities they enjoyed before GIST. Elsye Walker and Stijn Belmans, faced those changes and decided they wouldn’t accept an altered version of life.

By |2021-10-28T15:24:06-04:00October 28th, 2021|Member Stories, News, Newsletter|

Thriving & Challenging Yourself While Living with GIST, Stijn, Part 2

GIST patients face many obstacles and challenges to get to a place where they’d say they were thriving. Physical challenges from surgeries, pain and side effects can severely change the lifestyle and activities they enjoyed before GIST. Elsye Walker and Stijn Belmans, faced those changes and decided they wouldn’t accept an altered version of life.

By |2021-10-28T15:47:53-04:00October 28th, 2021|Member Stories, News, Newsletter|

A Conversation with a Few of Our Global GIST Mentors

n June 2021, we trained seven LRG members from Austria, Canada, Chile, India, and Singapore. LRG’s Global GIST Mentors are survivors or caregivers who volunteer their time, energy, and talent to support others.

By |2021-12-29T15:29:07-05:00October 28th, 2021|Global, News, Newsletter, Patient Support|

Tissue Testing Project

The Life Raft Group (LRG) is providing you with this information to let you know that comprehensive genomic profiling, also known as biomarker testing or molecular testing, is a crucial step in understanding the genomic factors that play a role in a GIST diagnosis. Bayer Pharmaceuticals, in partnership with The Life Raft Group (LRG), has extended a research collaboration to broaden access to comprehensive genomic testing (CGT) for Gastrointestinal Stromal Tumor (GIST) patients.

By |2021-11-04T10:18:38-04:00October 27th, 2021|Mutational Testing, News|
Go to Top